Articles

HIF1A is a critical downstream mediator for hemophagocytic lymphohistiocytosis

Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA;Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA;Laboratory of Oncology, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Japan
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA;Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA;State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA;Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China;University of Chinese Academy of Sciences, Beijing, China
Key Laboratory of Genomic and Precision Medicine, Beijing Institute of Genomics, Chinese Academy of Sciences, China;University of Chinese Academy of Sciences, Beijing, China
Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China
State Key Laboratory of Experimental Hematology, Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin, China
Perinatal Institute, Division of Pulmonary Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital, OH, USA
Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, OH, USA
Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children’s Hospital, OH, USA
Department of Hematology, Zhujiang Hospital, Southern Medical University, Guangzhou, China
Division of Experimental Hematology and Cancer Biology, Cincinnati Children’s Hospital Medical Center, OH, USA
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.174979